Experts review biotherapeutics for the prevention of C difficile infection, including probiotics, fecal microbiota transplantation, and nontoxigenic C difficile.
All articles by Larry K. Kociolek, MD, MSCI, and Stanford T. Shulman, MD
Experts review novel antibiotic therapies that may limit the impact on the gut microbiome, as well as passive immunization products that may bolster the immune response to C difficile toxins and possibly reduce the frequency of toxigenic strains.
Publish Date
Drs Kociolek and Shulman, from the division of infectious diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago in Illinois, review all the current vaccine candidates in development for Clostridium difficile infection.
Publish Date
-
Latest News Your top articles for Friday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses